| Literature DB >> 29303051 |
Hsin-Jung Ho1, Hitoshi Shirakawa1,2, Puspo E Giriwono1,3, Asagi Ito1, Michio Komai1.
Abstract
Isoprenoids play widely differing roles in various physiological processes in animals and plants. Geranylgeraniol (GGOH) is an isoprenoid found in plants, and is an important metabolic derivative in the isoprenoid/cholesterol synthesis pathway. Earlier studies focused on GGOH's ability to improve the side effects of bisphosphonate therapy by regulating the mevalonate pathway. More recently, the mevalonate pathway-independent effects of GGOH have been described, including anti-inflammatory, anti-tumorigenic, and neuroprotective activities. It is noteworthy that GGOH regulates the steroidogenesis pathway in testis-derived I-10 tumor cells. Testosterone is a hormone produced via steroidogenesis in testicles and plays a role in fetal development and the male reproductive system. GGOH enhanced testosterone and progesterone (its precursor) levels in I-10 cells by activating adenylate cyclase via cAMP/PKA signaling, without altering phosphodiesterase activity. These findings highlight the potential benefits of GGOH as a therapeutic agent for low testosterone levels, such as late-onset hypogonadism in men.Entities:
Keywords: AC: adenylate cyclase; FOH: farnesol; GGOH: geranylgeraniol; GGPP: geranylgeranyl diphosphate; GOH: geraniol; Geranylgeraniol; IBMX: 3-isobutyl-1-methylxanthine; MDL: MDL-12,330A; PDE: phosphodiesterase; PKA: protein kinase A; StAR: steroidogenic acute regulatory protein; cAMP/PKA; progesterone; steroidogenesis; testosterone
Mesh:
Substances:
Year: 2018 PMID: 29303051 DOI: 10.1080/09168451.2017.1415129
Source DB: PubMed Journal: Biosci Biotechnol Biochem ISSN: 0916-8451 Impact factor: 2.043